Loading clinical trials...
Loading clinical trials...
Bioactive Dairy Lipids to Manage Cardiometabolic Risk in Obesity
It is a randomized parallel arm intervention study in adults with severe obesity. The objective is to demonstrate that within a dietary handling for weight loss, the daily ingestion during 3 months of whole dairy products enriched with milk polar lipids or whole dairy products decreases to a greater extent fasting plasma apolipoprotein B concentrations than the daily ingestion of low-fat dairy products (control group). Metabolic parameters will be assessed before and after the 3-month intervention, both at fasting and in postprandial period after the consumption of standardized meals.
Age
18 - 70 years
Sex
ALL
Healthy Volunteers
No
Centre de Recherche en Nutrition Humaine Rhône-Alpes
Pierre-Bénite, France
Centres Hospitalier Lyon Sud, Service d'Endocrinologie-Diabète-Nutrition
Pierre-Bénite, France
Start Date
June 28, 2023
Primary Completion Date
October 1, 2026
Completion Date
October 1, 2026
Last Updated
June 18, 2025
75
ESTIMATED participants
Low-fat dairy products
OTHER
Whole-fat dairy products
OTHER
Milk polar lipid enriched whole-fat dairy products
OTHER
Lead Sponsor
Hospices Civils de Lyon
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07461610